Archives Publications

Home » Publications » Page 5

High Grade B Cell Lymphoma (English)

High-grade B-cell lymphoma is an aggressive category of non-Hodgkin lymphoma that includes subtypes defined by specific genetic mutations, most notably those involving the MYC and BCL2 proteins. This resource covers how it is recognized and distinguished from similar lymphomas, what chemoimmunotherapy regimens are most commonly used, and what options are available for patients whose disease relapses or becomes refractory. It also includes an overview of therapies currently under investigation in clinical trials.

Diffuse Large B-Cell Lymphoma (DLBCL) & Relapsed/Refractory DLBCL (English)

Diffuse large B-cell lymphoma is the most common form of non-Hodgkin lymphoma, accounting for roughly 1 in 3 new B-cell NHL diagnoses in the United States. This resource covers how it is diagnosed and staged, the subtypes that can affect prognosis and treatment decisions, and the full range of options available from initial chemoimmunotherapy through relapsed or refractory disease. It also includes guidance on self-advocacy, therapies currently under investigation, and questions to bring to your healthcare team.

Resources for Financial Assistance (English)

A lymphoma diagnosis can create real financial strain, from medical bills and insurance challenges to lost income and transportation costs. This resource is a practical guide to navigating those challenges, covering how to protect your financial assets, know your rights at work, and find assistance programs for medications, housing, travel, and more. It includes a comprehensive directory of organizations and industry-sponsored programs that can help patients access the support they need.

Diagnostic and Biomarker Testing (English)

Getting an accurate lymphoma diagnosis starts with the right tests, and a biopsy is the only way to confirm it. This resource walks through the diagnostic process, including the different types of biopsies, imaging scans, and blood tests used to identify and stage lymphoma. It also explains biomarker testing: what it is, how it helps personalize treatment decisions, and how patients can access it.

Chronic Lymphocytic Leukemia (CLL) (Spanish)

Entendiendo la Leucemia Linfocítica Crónica o Linfoma Linfocítico de Células Pequeñas (LLC o LLCP) Download Tabla 1. Sistema de estadificación de Rai para la LLC o el LLCP Grado Descripción Grupo de riesgo 0 • Linfocitosis de la sangre (aumento…

Chronic Lymphocytic Leukemia (CLL) (English)

Chronic lymphocytic leukemia and small lymphocytic lymphoma are two forms of the same slow-growing blood cancer, differing only in where the cancer cells are primarily found. This resource covers how CLL/SLL is diagnosed and staged, when treatment is recommended, and the full range of targeted therapies, immunotherapy, and chemoimmunotherapy options available. It also addresses measurable residual disease testing, guidance on self-advocacy, and questions to bring to your care team.

Care Partner (Spanish)

Entendiendo el linfoma para cuidadores Descarga Lymphoma Research Foundation publica la serie de hojas informativas Entendiendo el Linfoma y la LLC con el propósito de informar y educar a los lectores. Los datos y las estadísticas se obtuvieron utilizando la…

Care Partners

Caring for a loved one with lymphoma is one of the most meaningful things you can do, and one of the most demanding. This resource is written for care partners, covering the practical, medical, and emotional sides of the role, from attending appointments and managing medications to supporting children and teens through a difficult time. It also addresses the unique responsibilities of caring for someone undergoing CAR T-cell therapy or bispecific antibody treatment, and reminds care partners that taking care of themselves is just as important.